PT. Penta Valent (IDX:PEVE) - Stock Price, News & Analysis

PEVE Stock Overview

PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia.

PEVE fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	4/6
Financial Health	4/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (10.3x) is below the ID market (14.9x)

Earnings grew by 53.6% over the past year

Risk Analysis

High level of non-cash earnings

Does not have a meaningful market cap (IDR374B)

PT. Penta Valent Tbk Competitors

Millennium Pharmacon International

IDX:SDPC

Rp179.6b

Multi Medika Internasional

IDX:MMIX

Rp120.0b

Itama Ranoraya

IDX:IRRA

Rp738.8b

Enseval Putera Megatrading

IDX:EPMT

Rp6.3t

Price History & Performance

Summary of all time highs, changes and price drops for PT. Penta Valent
Historical stock prices
Current Share Price	Rp212.00
52 Week High	Rp216.00
52 Week Low	Rp135.00
Beta	0
1 Month Change	21.14%
3 Month Change	24.71%
1 Year Change	23.98%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	6.00%

Recent updates

Shareholder Returns

	PEVE	ID Healthcare	ID Market
7D	12.8%	2.6%	0.6%
1Y	24.0%	0.9%	1.7%

Return vs Industry: PEVE exceeded the ID Healthcare industry which returned 0.9% over the past year.

Return vs Market: PEVE exceeded the ID Market which returned 1.7% over the past year.

Price Volatility

Is PEVE's price volatile compared to industry and market?
PEVE volatility
PEVE Average Weekly Movement	5.7%
Healthcare Industry Average Movement	4.9%
Market Average Movement	5.2%
10% most volatile stocks in ID Market	12.1%
10% least volatile stocks in ID Market	2.3%

Stable Share Price: PEVE has not had significant price volatility in the past 3 months.

Volatility Over Time: PEVE's weekly volatility (6%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1968	1,019	- Sukismo	www.pentavalent.co.id

PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia. The company offers over the counter drug products; medical support devices, such as blood pressure monitors, nebulizer, kateter, and others; reaction materials, including blood sugar tests, pregnancy tests, or rapid tests for Covid19, drug tests, and others; and food supplements comprising minerals and nutrients. It also provides products for beauty and skin care, including makeup, perfume, skin nutrition, and other products; and daily cleaning and hygiene equipment and supplies, such as soaps, shampoos, toothpastes, lotions, and others.

PT. Penta Valent Tbk Fundamentals Summary

How do PT. Penta Valent's earnings and revenue compare to its market cap?
PEVE fundamental statistics
Market cap	Rp374.31b
Earnings (TTM)	Rp36.17b
Revenue (TTM)	Rp2.48t

10.3x

P/E Ratio

0.2x

P/S Ratio

Is PEVE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PEVE income statement (TTM)
Revenue	Rp2.48t
Cost of Revenue	Rp2.18t
Gross Profit	Rp301.03b
Other Expenses	Rp264.85b
Earnings	Rp36.17b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	20.49
Gross Margin	12.12%
Net Profit Margin	1.46%
Debt/Equity Ratio	33.3%

How did PEVE perform over the long term?

See historical performance and comparison

PT. Penta Valent IDX:PEVE Stock Report